Thursday, 28th August Australian Diabetes Society and the Australian Diabetes Educators Association Annual Scientific Meeting 2014

"New advances of Diabetes Conversations with Best practices around the world"

Speaker: Barbara Eichorst, MS, RD, CDE

Diabetes Conversations features Conversation Map™ tools created and designed by Healthy Interactions Inc., in collaboration with the International Diabetes Federation, sponsored by Eli Lilly and Company.

"Current and future trials shaping the landscape of diabetes treatment"

Chairperson and contributor: Associate Professor Marg McGill

Speaker: Professor Rury Holman

This breakfast session will provide a global perspective of both current and future diabetes trials. Presenter, Professor Rury Holman is involved in multiple trials currently assessing different agents and different aspects of diabetes management. Professor Holman's presentation will provide a comprehensive understanding of the clinical evidence to come and attendees will have an opportunity to ask many important questions surrounding the management of type 2 diabetes now and into the future.

"Diabetes and pregnancy – Latest updates"

Speakers: Prof. David McIntyre, Ms Alison Barry, and Mrs Amanda Bartlett

Pregnancies complicated by diabetes are at an increased risk of adverse foetal and maternal outcomes and longer-term health problems in offspring. Based on the long experience with their use, the current insulin gold standards in pregnancy include short-acting insulin and neutral protamine hagedorn (NPH). Given that evidence for long-acting insulin analogues in pregnancy has been lacking, the outcomes of the multinational, non-inferiority, randomised trial of insulin detemir versus NPH is timely. Insulin detemir was not inferior to NPH and was as well tolerated with regards to perinatal outcomes. These data support the Category A listing of insulin detemir, with implications for diabetes management before and during pregnancy.

Gestational diabetes mellitus (GDM) is associated with short and long term risks to mother and infant. Yet, there is considerable controversy as to how to diagnose GDM and provide optimal management during and after pregnancy. The Australasian Diabetes in Pregnancy Society (ADIPS) originally formulated recommendations for the testing and diagnosis of gestational diabetes mellitus (GDM) in 1991. In May 2013, ADIPS elected to revise these guidelines. This session will discuss the current GDM diagnostic criteria, and provide practical guidance for the management and follow up of GDM in general practice.

"Use of evidence in clinical practice: should we apply treatment guidelines or clinical judgement?"

Chairperson: Richard Morecroft

Speakers: 
Prof Ele Ferrannini, University of Pisa, Italy
A/Prof Sophia Zoungas, Monash University, VIC
W/Prof Tim Davis, University of Western Australia, WA
Dr Gary Deed, Mediwell, QLD

Come join us for a stimulating panel discussion, hosted by Richard Morecroft, on how individualisation of treatment works in practice in Australia and Europe, and what this means for the health outcomes of patients with Type 2 Diabetes Mellitus. Hear interactive discussion of how the panel of Ele Ferrannini, Tim Davis, Sophia Zoungas and Gary Deed see individualisation of care evolving in their respective parts of the health system, and how they approach individualisation in their practice. Discussion will no doubt be informed by the ADA/EASD 2012 position statement, the Australian guidelines for the treatment of type 2 diabetes, and explore the challenges in aligning evidence-based best-practice with health delivery and reimbursement considerations in Europe and Australia. Listen to discussion of both the European and Australian experience with the SGLT2 inhibitor class and where the panel see them fitting into their clinical practice.

Includes presentation of next years award.

*Recorded Session*

• Collaboration - A Pathway for service delivery in Rural Communities - Shirley Cornelius

*Recorded Session*

*GP CME Eligible Session*

08.30 – 08:40   Introduction
Dr Jennifer Conn 

08:40 –0 9:10   Understanding the consumer perspective Ms Renza Scibilia
Ms Jennifer Coburn 

9:10 – 9:40   Consulting skills for supporting self-management Dr Christel Hendrieckx Dr Alison Nankervis
Dr Jennifer Conn 

9:40 – 10:10   Consulting skills for optimising mental health
Dr Carol Silberberg 

10:10 – 10:30   Panel discussion Dr Jennifer Conn Ms Renza Scibilia Ms Jennifer Coburn Dr Christel Hendrieckx Dr Alison Nankervis Dr Carol Silberberg 

• Enhancing your consulting skills: Supporting self-management and optimising mental health in people who have Type 1 Diabetes - Jennifer Conn

• VEGF and the endothelium in insulin resistance and exercise - Lindsay Wu
• Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes - Pierre Scotney
• Endothelial progenitor cells enhance islet engraftment, influence beta cell function and modulate islet connexin 36 expression - Claire F Jessup
• tbc - David Le Couteur

• The Effect of Weight Loss on Indigenous Australians with Diabetes: A study of Feasibility, Acceptability and Compliance for Laparoscopic Adjustable Gastric Banding - John Wentworth
• New Insulin Glargine 300 U/mL: Glycaemic Control and Hypoglycaemia in Insulin Naïve People with T2DM (EDITION 3) - Stephen Twigg
• Dual Add-On Therapy in Poorly Controlled Type 2 Diabetes on Metformin: Randomized, Double-Blind Trial of Saxagliptin +Dapagliflozin vs. Saxagliptin and Dapagliflozin Alone  - William Cook
• Lixisenatide added to basal insulin reduces glycaemic variability in patients with type 2 diabetes mellitus - David O'Neal
• Are eggs good for people with type 2 diabetes mellitus? The DIABEGG study - Tania P Markovic
• How effective are GLP-1 agonists in real world practice - a multi centre study from the Australian S4S- DINGO - Diabetes Informatics Group - David M Hoffman
• Efficacy and safety of once-daily biphasic insulin aspart 70/30 (BIAsp 30) with sitagliptin and twice-daily BIAsp 30 with or without sitagliptin in patients with type 2 diabetes – the Sit2Mix trial - Sultan Linjawi
• Liraglutide 3.0 mg Reduces the Prevalence of Prediabetes and Delays Onset of Type 2 Diabetes in Overweight and Obese Adults: Results from SCALE Obesity and Prediabetes, a Randomized, Double-blind and Placebo-controlled 56-week Trial - Ian Caterson

• PKA-mediated potentiation of acute insulin release enhances insulin action and reverses glucose intolerance. - Barton Wicksteed
• NODk compared to C57BL/10 Mice are more Prone to Islet Beta-Cell Failure Due to Greater Susceptibility to Endoplasmic Reticulum Stress. - Viviane Delghingaro-Augusto
• Depletion of beta cell heparan sulfate (HS) in T2D-prone db/db mice results from diminished heparan sulfate proteoglycan (HSPG) core protein levels - Charmaine Simeonovic
• ISLET TRANSPLANT SITES FOR HUMAN AND MURINE ISLETS. - Rebecca A Stokes
• Comparative analysis of Insulin-producing cells in pancreas, gallbladder and the brain - Wilson Wong
• Genetic Deletion of the Endoplasmic Reticulum Gene Herpud1 Results in Impaired Insulin Secretion - Diane Vue
• Pancreas-specific Deletion of Bmpr1a Impairs Glucose Homeostasis Linked to Overexpression of Tph1 - Fang-Xu Jiang
• Recessive tolerance to proinsulin in early life is sufficient to prevent autoimmunity in NOD mice. - Gaurang Jhala

*Recorded Session*

• How Can Genetics Help us Understand and Treat Type 2 Diabetes? - Alan Attie

*Recorded Session*

*GP CME Eligible Session*

• Lessons from the Australian National Diabetes Audit (ANDA) - Sophia Zoungas
• Measuring beyond glycaemia: the importance of other quality indicators - Trisha Dunning
• The USA Experience - Teresa Pearson

• Organisational and health professional factors impacting on insulin initiation: An exploratory qualitative study  - Jo-Anne Manski-Nankervis
• Individualised medicine education for people with type 2 diabetes - Sally Savage
• The lived experience of diabetes educators in educating people with type 2 diabetes who have a fear of injections - Ahmad AHW Wibisono
• Label reading, is as easy as 1, 2, 3 – The online ‘Healthy Shopping’ - Michelle Tong
• Benefits of GLP-1 Analogue and Insulin Combinations in a Nurse Practitioner Supported Service - Giuliana Murfet

• Communicating Diabetes to Culturally and Linguistically Diverse Clients - Angela Simons
• Driving: Accelerating the Licence Review Process - Heather Hart
• The Nurse Practitioner role in pre admission diabetes management. - Marlene Payk
• Decreasing risks of medication errors in patients prescribed Humulin R U-500 - Denise J Bennetts
• Evaluation of Education Program Accompanying a New Subcutaneous Insulin Chart - Kirsty Boltong

*Recorded Session*

• Metabolomics and Mitochondria in Human Diabetic Nephropathy:  New Insights and Pathway for Therapeutics - Kumar Sharma

*Recorded Session*

• The natural history of diabetes: A view from the West - Timothy Davis

*Recorded Session*

• Eye Care for Diabetes, an Indigenous Perspective - Hugh Taylor

*Recorded Session*

• Retrospective audit to describe medical nutrition therapy provided for patients with type 1 diabetes in a Young Adult Diabetes Service - Lisa Cochrane
• ADDRESSING INEFFICIENCIES OF INPATIENT REFERRALS FOR DIABETES EDUCATION TO ASSIST RESOURCE ALLOCATION AND DIABETES DISCHARGE PLANNING - Katie Marley
• Changes to the ADEA Credentialling Program - Rachel A McKeown
• Lixisenatide Improves Treatment Satisfaction in Adults with Type 2 Diabetes Regardless of Timing of Administration - Jane Speight
• Study Protocol: Psychological Insulin Resistance amongst Torres Strait Islanders with Type 2 Diabetes - Sean Taylor
• Developing a resource suite for independently living older people with diabetes - Caroline Thomas
• A model for integrated client services for HARP Diabetes Foot Service clients with complex and/or psychosocial needs. - Mia Williams
• An integrated primary/specialist community model of diabetes care: the role of the Credentialed Diabetes Educator - Tien-Wen Jane Tsai

• The relationship between fat mass, insulin sensitivity and insulin secretion varies between Caucasian, Indian-Subcontinental and Oriental women after a pregnancy complicated by gestational diabetes. - Jaime Lin
• Maternal Body Mass Index (BMI) and Associated Adverse Risk in Women with Gestational Diabetes   - Esther Tan
• What is the Relationship Between Gestational Weight Gain, HbA1c, and Total Insulin Requirements During the Third Trimester of Pregnancy? - Kharis Burns
• TELEMEDICINE FOR GESTATIONAL DIABETES MELLITUS: A SYSTEMATIC REVIEW - Tshepo Rasekaba
• Metformin in Gestational Diabetes. Effect on Maternal and Perinatal outcome. - Chamica Wijesinghe
• INSULIN THERAPY IN GESTATIONAL DIABETES Impact of the New ADIPS Guidelines on Management of Gestational Diabetes Mellitus at Flinders Medical Centre (FMC) –An Audit of Blood Glucose Monitoring in Pregnant Women in a 9-Month Period - Jasper Sung
• Pregnancy outcomes after unintentional exposure to vildagliptin - Päivi M. Paldánius
• miRNA biomarkers for early prediction of adverse pregnancy outcomes in obese pregnant women - Erandi Hewawasam
• Albuminuria in pregnant women with type 2 diabetes in the Northern Territory - Kannan Bakthavatsalam
• Complications and costs associated with diabetes in pregnancy: a retrospective analysis - Katherine Davies
• The peripartum management of glycaemia in women with type 1 diabetes. - Naomi Achong
• Glycaemic behaviour during breastfeeding in type 1 diabetes using continuous glucose monitoring. - Naomi Achong
• Accuracy of women’s self-perception of body-weight and Type 2 diabetes risk at 3 months after a pregnancy complicated by gestational diabetes: does it matter? - Allison Sigmund
• Testing for diabetes after gestational diabetes: Does agreement between the post-partum 75g oral GTT and HbA1c improve one to three years later? - Teresa Lam
• GLUCOKINASE MONOGENIC DIABETES IN A MULTIETHNIC GESTATIONAL DIABETES COHORT: PERFORMANCE OF NEW PREGNANCY-SPECIFIC SCREENING CRITERIA - Victoria L Rudland
• Mistaken type 1 diabetes: case report of an INS gene mutation - Angeline Shen
• Type 2 diabetes is not always what is seems – a case of MODY-2 diabetes - Julia E Shrosbree
• Maturity-onset diabetes of the young type 5 (MODY5) in a family with diabetes and mild kidney disease diagnosed by whole exome sequencing. - John M Wentworth
• Complication differences in early versus late diagnosis of autoimmune diabetes in adults  - Spiros Fourlanos
• Mortality in younger vs older onset type 2 diabetes in Anglo-Celts: The Fremantle Diabetes Study Phase II - Jocelyn Drinkwater
• Prevalence of Obesity in elderly diabetes patients in North Queensland - Divya Srivastava
• Does impaired fasting glucose impact health, incident disease and 2-year mortality in the elderly? The Sydney Memory and Ageing Study. - Katherine Samaras
• Glycaemic control in elderly people with T2DM in clinical trial, observational and individualised care settings - Päivi M. Paldánius
• Expectations and aspirations of elderly patients and physicians in the management of type 2 diabetes - Päivi M. Paldánius
• Relative contribution of adiposity and insulin resistance to bone mineral density in humans - Dorit Samocha-Bonet
• Comparison Of Mortality and Morbidity Outcomes In Hip Fracture Patients With And Without Diabetes - Pratyusha Naidu
• Cola kills: The Fremantle Diabetes Study Phase II - Michelle England
• The efficacy of omega-3 polyunsaturated fatty acids supplementation in overweight and obesity: a meta-analysis of randomized clinical trials - Yi-Yi Zhang
• Metabolic benefits of dietary prebiotics in human subjects: a systematic review of randomised controlled trials - Nicole J Kellow
• The influence of food-skills confidence on indices of dietary quality - Melissa Burton
• Is Intermittent Fasting of Particular Benefit in Type 2 Diabetes? Evidence from a Study of Gut Hormones, Appetite and Body Composition during Ramadan - Jencia Wong
• Not Sweet Enough - Anna Zheng
• The Australian Paradox is confirmed: updated evidence that refined sugars consumption is declining - Jennie C Brand-Miller
• Complementary and alternative medicine in diabetes (CALMIND) – a prospective study - Aaron C Tan
• Algorithms in type 2 diabetes management do not reflect knowledge of physicians about the benefits of early treatment - Päivi M. Paldánius
• Survey of metformin use amongst Endocrinologists and Endocrine Advanced Trainees in Australia - Weiwen Chen
• Real-life effectiveness of OADs as add-on therapy after monotherapy failure in patients with substantial hyperglycaemia (HbA1c ≥10.0%): a post-hoc analysis of the EDGE study - Päivi M. Paldánius
• Inter-regional differences in the real-world achievement of glycaemic control with dual OAD combinations for the treatment of T2DM - Päivi M. Paldánius
• Dipeptidyl peptidase-4 inhibitors as a third-line oral anti-hyperglycaemic agent in patients with type 2 diabetes mellitus: The impact of ethnicity - Belinda Brooks
• Influence of Baseline HbA_1c, Obesity Status and Age on the Effects of Vildagliptin +/- Metformin Studied in a Large Multiethnic Population with Type 2 Diabetes: GUARD study - Reynaldo Rosales
• Real-life observation of the effectiveness and tolerability of vildagliptin in Hispanic Native American T2DM patients - Päivi M. Paldánius
• Real World Clinical Use of Vildagliptin with or without Metformin in a Large Multiethnic Population with Type 2 Diabetes Mellitus: GUARD Study - Reynaldo Rosales
• Vildagliptin Efficacy in combination with metfoRmIn For earlY treatment of type 2 diabetes mellitus (VERIFY) - Päivi M. Paldánius
• Real world effectiveness of vildagliptin vs other OADs as add-on to sulphonylureas in T2DM patients not receiving metformin: post-hoc analysis from the EDGE study - Päivi M. Paldánius
• Systematic literature review of clinical trials of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes and renal impairment - Merlin Thomas
• Exenatide (Glucagon-like Peptide-1 agonist) use in an outpatient clinic - Dinesh CJ Mahendran
• Lixisenatide as add-on treatment among patients with different β-cell function levels as assessed by HOMA-β index - Michael Horowitz
• Canagliflozin (CANA) Added on to Dipeptidyl Peptidase-4 Inhibitors (DPP-4i) or Glucagon-like Peptide-1 (GLP-1) Agonists With or Without Other Antihyperglycemic Agents (AHAs) in Type 2 Diabetes Mellitus (T2DM) - Carol Wysham
• Canagliflozin (CANA) in subjects with type 2 diabetes mellitus (T2DM) inadequately controlled on sulfonylurea (SU) monotherapy: A CANVAS substudy - Greg Fulcher
• Effect of Canagliflozin (CANA) in Patients With Type 2 Diabetes Mellitus (T2DM) Based on Age and Estimated Glomerular Filtration Rate (eGFR)  - Richard E Gilbert
• Glycemic Efficacy Of Canagliflozin (Cana) By Baseline A1c And Known Duration Of Type 2 Diabetes Mellitus (T2dm) - Lawrence Blonde
• Efficacy and safety of liraglutide versus placebo as add-on to existing diabetes medication in subjects with type 2 diabetes (T2DM) and moderate renal impairment (LIRA-RENAL) - Sabina Furber
• Effectiveness and tolerability with liraglutide among patients with type 2 diabetes – 2-year data from EVIDENCE: a prospective, follow-up, post-marketing study - Mirella Daja
• Efficacy and safety of liraglutide vs. placebo when added to basal insulin analogues in patients with type 2 diabetes (LIRA-ADD2BASAL) - Alana Philips
• Basal Plus compared with Biphasic insulin in type 2 diabetes: A post-hoc, subset analysis of the Australian data from the LANSCAPE trial. - Neale Cohen
• New Insulin Glargine 300 U/mL: Glycaemic Control and Hypoglycaemia in a Meta-analysis of Phase 3a EDITION Clinical Trials in People with T2DM - Stephen Twigg
• Factors affecting continuous subcutaneous insulin infusion experience and clinical outcome in adults with type 1 diabetes mellitus across a spectrum of healthcare settings - Tzu-Ting Lin
• Helping patients to titrate to the right insulin dosage improves fasting blood glucose irrespective of the titration regimen chosen: Real world insights from a patient support program - Olga Lutzko
• Pharmacodynamic/pharmacokinetic (PK/PD) profile of new insulin glargine 300U/ml (Gla-300) during euglycaemic clamp in patients with type 1 diabetes. - Stephen Twigg
•  A pilot study of factors associated with better glycaemic control in insulin pump therapy - Wanling Wen
• The Efficacy of Transdermal Buprenorphine (Norspan®) in the Treatment of Diabetic Peripheral Neuropathic Pain - Ellen M Landy
• PREVIEW: PREVENTION OF DIABETES THROUGH LIFESTYLE INTERVENTION AND POPULATION STUDIES IN EUROPE AND AROUND THE WORLD. On behalf of the PREVIEW Consortium.  - Jennie C Brand-Miller
• Experience of three-times-daily biphasic insulin aspart in clinical practice: results from the A₁chieve study - Ruchi Bakshi
• Beta cell response to intravenous glucose improves following gastric band surgery and predicts diabetes remission: secondary outcomes of a randomised controlled trial. - John M Wentworth
• Use of structured self-monitoring of blood glucose improves HbA1c without increasing diabetes-related distress in Australian adults with non-insulin-treated type 2 diabetes: Preliminary results of the STeP IT UP Trial - Jane Speight
• Professional (Retrospective) Continuous Glucose Monitoring: a retrospective analysis of its use in an outpatient clinic setting - Michelle So
• Point-of-Care Testing in Diabetes Management – A Very Useful Technology - Heather Halls
• Are diabetes patients having the minimum pathology monitoring for their Annual Cycle of Care [ACOC]? - Chrys Michaelides
• Teratogenic effects of hyperglycaemia; case reviews. - Himali Suwandarathne
• Hyperglycaemia in glucocorticoid-based chemotherapy for haematological malignancies. - Shannon E McCarthy
• Hypoglycaemia in type 1 diabetes secondary to adrenal cortical insufficiency - May Lea Ong
• Post prandial capillary venous glucose gradient in type 1 diabetes: Magnitude and clinical associations - Helen Lunt
• THE AUSTRALASIAN DIABETES DATA NETWORK (ADDN): A POTENTIAL TOOL TO FACILITATE IMPROVED TRANSITION - Helen Phelan
• Inpatient Hyperglycaemia Management; not much improvement yet! - Meg Ritchie
• Are we running too high?  (The glycaemia profile of medical and surgical acute care wards in a south-west Sydney tertiary referral centre) - Nadia Manzoor
• Prevalence of Diabetes amongst Inpatients at a Metropolitan Teaching Hospital - Joanne E Taylor
• Inpatient dysglycaemia at a regional hospital – where are the problems? - Anis Zand Irani
• Review of inpatient management of dysglycaemia in Diabetes Mellitus by general and specialist services in a south-west Sydney tertiary hospital. - Lili Yuen
• Diabetic inpatients: a missed opportunity - Ali Sharafi
• Audit: Comparing the management of diabetic ketoacidosis (DKA) at two Queensland hospitals to the Queensland Health DKA protocol (QHDP). - Shanthi Carnelio
• Factors Associated With Medical Inpatient Stay Duration Of Patients With Diabetes Mellitus Admitted To A Community Public Hospital - Melissa Lee
• Glycaemic control and cardiovascular risk in Australians with Diabetes, results of the 2013 Australian National Diabetes Audit – Australian Quality Clinical Audit (ANDA-AQCA) - Yee -Ming Melody YM Cheung
• A multidisciplinary service for diabetes optimisation: a retrospective audit - YeeMing Cheung
• Integrated Chronic Disease Management in Primary-Secondary Care: A systematic literature review of the evidence. - Martin Connor
• Blood Pressure control in clinic patients with Diabetes - Geetha Theverkalam
• How does Australian Diabetic Foot Screening rate on an International Stage? - Ainslie M Davies
• The Prevalence of Diabetes Related Foot Disease in the Australian Population, Experience from the 2013 Australian National Diabetes Audit – Australian Quality Clinical Audit (ANDA-AQCA). - Yee -Ming Melody Cheung
• Past health professional attendance for foot care in people with diabetes:  The Foot Disease in Inpatients Study (FDIS) - Pete A Lazzarini
• Diabetic Foot Disease and opportunities for enhanced care: an audit of the cardiovascular risk factors in patients presenting to a tertiary referral High Risk Foot Service - Lili Yuen
• Point Prevalence Survey Of High-Risk Foot Disorders In Adult Inpatients Of A Tertiary Public Hospital - Gerard T Chew
• Clinical outcomes of diabetic foot ulceration over two years since the inception of a High Risk Foot Service in a tertiary South-Western Sydney hospital. - Min Ling
• Do foot ulcers affect physical activity, energy expenditure and sleep?  Diabetic foot activity sleep study - Helen Sheahan
• Changes in Circulating Monocyte Number and Profile During Foot Ulcer Healing in Diabetic Patients - Danqing Min
• Percutaneous Isolated Limb Perfusion of the Infected Diabetic Foot - Melissa Byrne
• How health-care in diabetes and chronic kidney disease can be improved: general practitioners’ views - Clement Lo
• Improving health-care in diabetes and chronic kidney disease: hospital health professionals’ views - Clement Lo
• Audit on the management and clinical outcome of patients treated in the Joint Diabetic-Renal Clinic (JDRC) at the Royal Darwin Hospital (RDH), Northern Territory - Ni Ni Khin
• Is there a relationship between glycaemic control and CKD rates in patients diagnosed with diabetes in GP - a sub study of the Mapping Glycaemic Control Across Australia Study (MGCAA) - Chrys Michaelides
• What proportion of diabetes patients are not having renal pathology monitoring? - Chrys Michaelides
• Dyslipidemia and its correlation with type 2 diabetes patients at different stages of proteinuria - Noura Al-Jameil
• Estimation of Serum Copper and Magnesium Levels in Diabetic Nephropathy Patients - Noura Al-Jameil
• Study of longitudinal renal function in patients with Type 1 Diabetes Mellitus (T1DM) - Hilary Thomson
• Chronic kidney disease and mortality in Aboriginals vs Anglo Celts with type 2 diabetes: The Fremantle Diabetes Study Phase II - Erin Latkovic
• Characteristics and achievement of metabolic targets in patients with type 2 diabetes enrolled in the Aboriginal Chronic Care Program at Budyari Community Health Centre based at Miller, NSW - Mahbub Hasan
• Risk factors for chronic disease in young Aboriginal and Torres Strait Islander Australians: an evaluation of preventive health care provision. - Bethany Crinall
• Serum vitamin D levels, diabetes and cardiometabolic risk factors in Aboriginal and Torres Strait Islander Australians. - Kanakamani Jeyaraman
• Evaluation of clinical outcomes from a multidisciplinary indigenous diabetes service in remote communities in Central Australia - Michele Mack
• Mortality in Aboriginals vs Anglo Celts with type 2 diabetes: The Fremantle Diabetes Study Phase II - Jacequeline Hall
• Clinical Profile of Diabetic Ketoacidosis in tertiary care hospital of Eastern Nepal - robin maskey
• Glycaemic status, atherogenic risk, and the risk of nephropathy in type 2 diabetes patients of Kavre, Nepal - Prabodh Risal
• Social and behavioural influences on glycaemic control in young adults with type 1 diabetes mellitus - Jessica Osan
• Expectations and aspirations of patients and physicians at the diagnosis of type 2 diabetes - Päivi M. Paldánius
• Associations between glycaemic control, disease burden and emotional well-being in adults with type 2 diabetes: preliminary analysis of baseline data from the Stepping Up Study - Jo-Anne Manski-Nankervis
• Online depression treatment for people living with diabetes: protocol and preliminary findings - Lisa Robins
• High baseline prevalence of depression and elevated HbA1c in patients with acute coronary syndrome: a report from the ADVENT study - John Oldroyd
• What research do adults with diabetes want? Analysis of 1211 qualitative responses to Diabetes MILES - Australia - Jane L Rich
• Vitamin D is related to glucose metabolism and chronic low-grade inflammation in healthy normoglycaemic individuals  - Aya Mousa
• Diabetes Myonecrosis: Rare complication of a common disease  - Tripti Joshi
• An unusual cause of marked insulin resistance in a patient with type 2 diabetes mellitus - Rajini Jayaballa
• Diabetes in a Nonpancreatectomized Adult with Nesidioblastosis - Anita Singh

*Recorded Session*

• Implementing the McKellar Guidelines for Managing Older People with Diabetes in Residential and other Care Settings (The Guidelines): some quality use of medicine issues - Trisha Dunning
• Caring for older people with diabetes: do guidelines help health professionals plan individualised care? - Trisha Dunning
• Community-dwelling Older People with Diabetes’ Perspective of Diabetes Self-Care. - Nicole Duggan
• STRATEGIES TO IMPROVE MANAGEMENT OF HYPOGLYCAEMIA IN SUB-ACUTE CARE - Julie Loughran

• A STUDY EXAMINING THE PHYSICAL, PSYCHOLOGICAL AND COGNITIVE EFFECTS OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION THERAPY (CSII) IN TYPE I DIABETES. - Sue Wyatt
• THE IMPORTANCE OF SCREENING FOR MILD DEPRESSION WITHIN A DIABETES SERVICE - Kay Wilhelm
• When Being Overweight is the Least of Your Problems - Lisa Engel
• Pathways to mental healthcare: online assessment and feedback report - Lisa Robins

*Recorded Session*

• Global deletion of Nox4 as well as podocyte specific Nox4 deletion attenuates albuminuria in diabetic nephropathy - Jay C Jha
• Novel Mouse Models of Diabetes Susceptibility in the Collaborative Cross Dissect Complex Pathogenesis of Type 2 Diabetes - Jessie Yang
• Microparticles are vectors for CD147-mediated hepatocyte injury and stellate cell activity in non-alcoholic steatohepatitis - Linda Ban
• The non-canonical NFκB pathway as a novel player in beta cell dysfunction in diabetes - Elisabeth K Malle
• Lowering glycation products in experimental autoimmune diabetes reduces islet inflammation through islet localised effects   - Danielle J Borg
• Skeletal muscle-specific glycogen synthase 1 gene (gys1) deletion in mice results in insulin resistance associated with reduced GLUT4 levels - Chrysovalantou Xirouchaki
• Therapeutic blockade of IL-6 trans-signaling increases adipogenesis, prevents adipose tissue inflammation and does not exacerbate liver steatosis or insulin resistance in obesity. - Michael J Kraakman
• Reduced glucose uptake in muscle of high fat-fed rats is associated with lower pyruvate dehydrogenase activity without changes in insulin signalling. - Lewin Small

• Are the Institute of Medicine targets for pregnancy weight gain appropriate in women with Gestational diabetes? - Tang Wong
• Metformin Treatment of Gestational Diabetes Results in Similar Glycaemic Control and Infant Outcomes but Less Maternal Weight Gain Than Insulin Treatment - Lorraine Pereira
• Maternal and birth outcomes of women with diabetes in pregnancy in the Northern Territory: PANDORA Study - I-Lynn Lee
• Maternal diet, fetal growth and body composition in women at high risk of gestational diabetes - Jennie Brand-Miller
• Gestational Weight Gain in Obese Women with Gestational Diabetes: Maternal and Baby Outcomes in a Multi-ethnic Cohort in South Western Sydney - Jeff R Flack
• Ethnic differences in pregnancy outcomes in women with Gestational Diabetes Mellitus - Robyn A Barnes
• Ethnic differences in gestational weight gain and pregnancy outcomes in women with Gestational Diabetes Mellitus - Robyn A Barnes
• Gestational diabetes mellitus and adverse pregnancy outcomes: experience from Victoria’s largest healthcare service - Sally Abell

• Hospital Morbidity Coding - Wendy Davis
• Administrative Data Sets and Clinical Quality Registries – Strengths and Weaknesses - Chris Reid
• Genetics in the “Big Data” Era: Strengths and Limitations  - Grant Morahan
• Pitfalls in meta-analyses and data pooling projects  - Dianna Magliano

Only ADS Members are able to attend the Annual General Meeting